CEOs Criticize Japan’s Slow Vaccine Push, Saying Growth at Risk
- Business leaders are becoming more vocal with their concerns
- Japan lags behind most OECD countries in vaccine rollout
This article is for subscribers only.
Business executives in Japan are starting to voice concerns over what they see as an unacceptably slow vaccine rollout in one of the world’s richest countries, a rare chorus of warnings over increasing risks to any economic recovery.
“Among developed nations, Japan is the biggest problem,” Takehiko Kakiuchi, chief executive officer of Mitsubishi Corp., said during a recent earnings briefing. As one of the country’s largest trading companies, Mitsubishi has broad visibility across all sectors of the economy, from heavy machinery and petrochemicals, to property and retail.